Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Olaf Witt

Showing results (161-170 of 242) with videos related to

Pageof 25
Sort By:
Neuropathology and Applied Neurobiology|October 16, 2024
DNA methylation-array interlaboratory comparison trial demonstrates highly reproducible paediatric CNS tumour classification across 13 international centresMihaela Chirica, Philipp Jurmeister, Daniel Teichmann, et al.
Neuro-Oncology Advances|February 3, 2025
Pediatric spinal high-grade glioma in the pediatric precision oncology registry INFORM: Identification of potential therapeutic targetsElke Pfaff, Kathrin Schramm, Mirjam Blattner-Johnson, et al.
Iscience|January 26, 2026
Preclinical drug screen identifies WEE1 inhibitor and vinca alkaloid as a combination treatment concept for Li-Fraumeni syndrome medulloblastomaAnna S Kolodziejczak, Florian Selt, Heike Peterziel, et al.
Acta Neuropathologica|December 17, 2015
Next-generation sequencing in routine brain tumor diagnostics enables an integrated diagnosis and identifies actionable targetsFelix Sahm, Daniel Schrimpf, David T W Jones, et al.
The Lancet. Oncology|June 6, 2020
Response assessment in paediatric low-grade glioma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) working groupJason Fangusaro, Olaf Witt, Pablo Hernáiz Driever, et al.
Cancer Cell|January 1, 2019
Comprehensive Analysis of Chromatin States in Atypical Teratoid/Rhabdoid Tumor Identifies Diverging Roles for SWI/SNF and Polycomb in Gene RegulationSerap Erkek, Pascal D Johann, Martina A Finetti, et al.
Journal of Neuro-Oncology|April 17, 2024
Rebound growth of BRAF mutant pediatric glioma cells after MAPKi withdrawal is associated with MAPK reactivation and secretion of microglia-recruiting cytokinesDaniela Kocher, Lei Cao, Romain Guiho, et al.
European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society|August 18, 2015
Strategies to improve the quality of survival for childhood brain tumour survivorsGesche Tallen, Anika Resch, Gabriele Calaminus, et al.
Neuropathology and Applied Neurobiology|December 18, 2020
Accurate calling of KIAA1549-BRAF fusions from DNA of human brain tumours using methylation array-based copy number and gene panel sequencing dataDamian Stichel, Daniel Schrimpf, Philipp Sievers, et al.
Acta Neuropathologica|September 18, 2021
GOPC:ROS1 and other ROS1 fusions represent a rare but recurrent drug target in a variety of glioma typesPhilipp Sievers, Damian Stichel, Martin Sill, et al.
Pageof 25

Showing results (161-170 of 242) with videos related to

Sort By:
Pageof 25
Neuropathology and Applied Neurobiology|October 16, 2024
DNA methylation-array interlaboratory comparison trial demonstrates highly reproducible paediatric CNS tumour classification across 13 international centresMihaela Chirica, Philipp Jurmeister, Daniel Teichmann, et al.
Neuro-Oncology Advances|February 3, 2025
Pediatric spinal high-grade glioma in the pediatric precision oncology registry INFORM: Identification of potential therapeutic targetsElke Pfaff, Kathrin Schramm, Mirjam Blattner-Johnson, et al.
Iscience|January 26, 2026
Preclinical drug screen identifies WEE1 inhibitor and vinca alkaloid as a combination treatment concept for Li-Fraumeni syndrome medulloblastomaAnna S Kolodziejczak, Florian Selt, Heike Peterziel, et al.
Acta Neuropathologica|December 17, 2015
Next-generation sequencing in routine brain tumor diagnostics enables an integrated diagnosis and identifies actionable targetsFelix Sahm, Daniel Schrimpf, David T W Jones, et al.
The Lancet. Oncology|June 6, 2020
Response assessment in paediatric low-grade glioma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) working groupJason Fangusaro, Olaf Witt, Pablo Hernáiz Driever, et al.
Cancer Cell|January 1, 2019
Comprehensive Analysis of Chromatin States in Atypical Teratoid/Rhabdoid Tumor Identifies Diverging Roles for SWI/SNF and Polycomb in Gene RegulationSerap Erkek, Pascal D Johann, Martina A Finetti, et al.
Journal of Neuro-Oncology|April 17, 2024
Rebound growth of BRAF mutant pediatric glioma cells after MAPKi withdrawal is associated with MAPK reactivation and secretion of microglia-recruiting cytokinesDaniela Kocher, Lei Cao, Romain Guiho, et al.
European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society|August 18, 2015
Strategies to improve the quality of survival for childhood brain tumour survivorsGesche Tallen, Anika Resch, Gabriele Calaminus, et al.
Neuropathology and Applied Neurobiology|December 18, 2020
Accurate calling of KIAA1549-BRAF fusions from DNA of human brain tumours using methylation array-based copy number and gene panel sequencing dataDamian Stichel, Daniel Schrimpf, Philipp Sievers, et al.
Acta Neuropathologica|September 18, 2021
GOPC:ROS1 and other ROS1 fusions represent a rare but recurrent drug target in a variety of glioma typesPhilipp Sievers, Damian Stichel, Martin Sill, et al.
Pageof 25